| Exosome-carried microRNA-375 inhibits cell progression and dissemination via Bcl-2 blocking in colon cancer F Zaharie, MS Muresan, B Petrushev, C Berce, GA Gafencu, S Selicean, ... J Gastrointestin Liver Dis 24 (4), 435-443, 2015 | 99 | 2015 |
| Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy B Petrushev, S Boca, T Simon, C Berce, I Frinc, D Dima, S Selicean, ... International journal of nanomedicine 11, 641, 2016 | 48 | 2016 |
| Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome A Jurj, L Pop, B Petrushev, S Pasca, D Dima, I Frinc, D Deak, ... Critical reviews in clinical laboratory sciences 55 (7), 501-515, 2018 | 31 | 2018 |
| MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation C Tomuleasa, S Fuji, A Cucuianu, M Kapp, V Pileczki, B Petrushev, ... Annals of hematology 94 (7), 1081-1092, 2015 | 26 | 2015 |
| Evaluation of cellular and molecular impact of zearalenone and Escherichia coli co-exposure on IPEC-1 cells using microarray technology C Braicu, S Selicean, R Cojocneanu-Petric, R Lajos, O Balacescu, ... BMC genomics 17 (1), 576, 2016 | 20 | 2016 |
| Minimal residual disease in chronic lymphocytic leukemia: A consensus paper that presents the clinical impact of the presently available laboratory approaches C Tomuleasa, C Selicean, S Cismas, A Jurj, M Marian, D Dima, S Pasca, ... Critical reviews in clinical laboratory sciences 55 (5), 329-345, 2018 | 18 | 2018 |
| Ruxolitinib-conjugated gold nanoparticles for topical administration: An alternative for treating alopecia? S Boca, C Berce, A Jurj, B Petrushev, L Pop, GA Gafencu, S Selicean, ... Medical hypotheses 109, 42-45, 2017 | 18 | 2017 |
| Modern lymphatic dissection techniques for preventing post renal transplant lymphocele CV Lucan, I Jurchis, M Suciu, SE Selicean, S Buttice Clujul Medical 90 (4), 416, 2017 | 16 | 2017 |
| MicroRNAs in liver malignancies. Basic science applied in surgery. M Muresan, F Zaharie, A Bojan, I Frinc, D Dima, S Selicean, GA Gafencu, ... Journal of BU ON.: official journal of the Balkan Union of Oncology 20 (2 …, 2015 | 14 | 2015 |
| Fibroblast dynamics as an in vitro screening platform for anti‐fibrotic drugs in primary myelofibrosis C Tomuleasa, S Selicean, G Gafencu, B Petrushev, L Pop, C Berce, A Jurj, ... Journal of cellular physiology 233 (1), 422-433, 2018 | 12 | 2018 |
| Mesenchymal stem cells in myeloproliferative disorders–focus on primary myelofibrosis SE Selicean, C Tomuleasa, R Grewal, G Almeida-Porada, ... Leukemia & lymphoma 60 (4), 876-885, 2019 | 9 | 2019 |
| Clinicopathological analysis of a case series of peripheral T-cell lymphomas, not otherwise specified, of lymphoepithelioid variant (Lennert's lymphoma). A Central European … GA Gafencu, SE Selicean, B Petrushev, A Cucuianu, D Dima, I Frinc, ... Human pathology 53, 192, 2016 | 9 | 2016 |
| GOLD NANOPARTICLES CONJUGATED WITH RITUXIMAB FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA S Boca, C Lucan, I Frinc, B Petrushev, T SIMON, C Berce, GA Gafencu, ... FARMACIA 64 (5), 688-698, 2016 | 6 | 2016 |
| How to Cite CV Lucan, I Jurchis, M Suciu, SE Selicean, S Buttice | | |
